Induction treatments with and without addition of one dose anthracycline to all-trans retinoid acid and arsenic in pediatric non-high-risk acute promyelocytic leukemia: study protocol for a randomized controlled trial

Abstract Background The treatment of all-trans retinoic acid (ATRA) and arsenical agent has revolutionarily improved the prognosis of acute promyelocytic leukemia (APL) both in adults and children. Nevertheless, coagulation disorder and differentiation syndrome (DS) are the main causes of early deat...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Zhong Fan, Xiu-Ya Huang, Dan-Ping Huang, Jie-Si Luo, Jia-Yin Su, Xiao-Li Zhang, Yu Li, Li-Na Wang, Cong Liang, Xue-Qun Luo, Li-Bin Huang, Yan-Lai Tang
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2024-12-01
Serija:	Trials
Teme:	Acute promyelocytic leukemia Children Arsenic trioxide Realgar-Indigo naturalis formula Chemotherapy
Online dostop:	https://doi.org/10.1186/s13063-024-08664-y
Oznake:	Označite Brez oznak, prvi označite!